Patent · US Active

Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment

US8137932B2 · kind B2 · utility

4Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2010
Grant dateMar 20, 2012
Priority date
Expiry dateDec 7, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method for stabilizing chimeric immunoglobulins or immunoglobulin fragments. Furthermore, the invention also provides a stabilized anti-EGP-2 scFv fragment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.